E. Dalmau
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
Papers in ⓘ
- Oncology 16
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 3
-
- Breast Cancer Treatment Studies 7
- Co-authors
- C. Casas (3 shared papers)José Luis González Montesinos (2 shared papers)Marina Lotti (1 shared paper)Jordi Remón (1 shared paper)Diego Márquez-Medina (1 shared paper)Teresa Morán (1 shared paper)Margarita Majem (1 shared paper)Noemı́ Reguart (1 shared paper)
In The Last Decade
E. Dalmau
26 papers receiving 650 citations
Peers
Comparison fields: 5 of 83
- Oncology 251
- Pulmonary and Respiratory Medicine 273
- Cancer Research 124
- Gastroenterology 38
- Molecular Biology 346
Countries citing papers authored by E. Dalmau
This map shows the geographic impact of E. Dalmau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Dalmau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Dalmau more than expected).
Fields of papers citing papers by E. Dalmau
This network shows the impact of papers produced by E. Dalmau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Dalmau. The network helps show where E. Dalmau may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Dalmau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 174 | |
| 2 | 2000 | 171 | |
| 3 | 2013 | 106 | |
| 4 | 2018 | 47 | |
| 5 | 2006 | 34 | |
| 6 | 2014 | 31 | |
| 7 | 2007 | 29 | |
| 8 | 2003 | 19 | |
| 9 | 1998 | 18 | |
| 10 | 2020 | 15 | |
| 11 | 2013 | 9 | |
| 12 | 2016 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2006 | 5 | |
| 15 | 2016 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2019 | 3 | |
| 18 | 2010 | 3 | |
| 19 | 2006 | 3 | |
| 20 | 2008 | 2 |
About E. Dalmau
E. Dalmau is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Transplantation and Gastroenterology, having authored 27 papers that have together received 695 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Advanced Breast Cancer Therapies (4 papers), Enzyme Catalysis and Immobilization (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Oncology (251 citations), Pulmonary and Respiratory Medicine (273 citations), Cancer Research (124 citations), Gastroenterology (38 citations) and Molecular Biology (346 citations). E. Dalmau has collaborated with scholars based in Spain, Mexico and Canada. Frequent co-authors include C. Casas, José Luis González Montesinos, Marina Lotti, Jordi Remón, Diego Márquez-Medina, Teresa Morán, Margarita Majem, Noemı́ Reguart, P. Lianes and Miguel Ángel Seguí. Their work appears in journals such as Journal of Clinical Oncology, Clinical & Translational Oncology, Clinical Breast Cancer, Journal of Biotechnology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.